Impact of Plant-Derived Compounds on Amyotrophic Lateral Sclerosis
Neurotoxicity Research · 2023-06 · 41 (3) · 288-309
DOI: 10.1007/s12640-022-00632-1 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neurotoxicity Research, online erschienen am 17.02.2023. Verfasst von Lucas Matheus Gonçalves de Oliveira und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Neurochemistry and Cell Biology, Department of Biochemistry and Biophysics, Institute of Health Sciences, Federal University of Bahia, …. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 241 Literaturangaben. Gefördert von: Coordenação de Apoio de Pessoal de Nível Superior, Conselho Nacional de Desenvolvimento Científico e Tecnológico.
Abstract (Originalsprache)
Amyotrophic lateral sclerosis (ALS) is a fatal illness characterized by progressive motor neuron degeneration. Conventional therapies for ALS are based on treatment of symptoms, and the disease remains incurable. Molecular mechanisms are unclear, but studies have been pointing to involvement of glia, neuroinflammation, oxidative stress, and glutamate excitotoxicity as a key factor. Nowadays, we have few treatments for this disease that only delays death, but also does not stop the neurodegenerative process. These treatments are based on glutamate blockage (riluzole), tyrosine kinase inhibition (masitinib), and antioxidant activity (edaravone). In the past few years, plant-derived compounds have been studied for neurodegenerative disorder therapies based on neuroprotection and glial cell response. In this review, we describe mechanisms of action of natural compounds associated with neuroprotective effects, and the possibilities for new therapeutic strategies in ALS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Neurochemistry and Cell Biology, Department of Biochemistry and Biophysics, Institute of Health Sciences, Federal University of Bahia, Salvador, Bahia, 40110-100, Brazil.
- Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield, UK.
- Institut Pasteur de Montevideo, Montevideo, Uruguay.
- Laboratory of Neurochemistry and Cell Biology, Department of Biochemistry and Biophysics, Institute of Health Sciences, Federal University of Bahia, Salvador, Bahia, 40110-100, Brazil. vdsilva@ufba.br.
- Laboratory of Neurochemistry and Cell Biology, Department of Biochemistry and Biophysics, Institute of Health Sciences, Federal University of Bahia, Salvador, Bahia, 40110-100, Brazil. costasl@ufba.br.
Förderung
- Coordenação de Apoio de Pessoal de Nível Superior
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
de Oliveira, L. M. G., Carreira, R. B., de Oliveira, J. V. R., do Nascimento, R. P., Dos Santos Souza, C., Trias, E., da Silva, V. D. A., & Costa, S. L. (2023). Impact of Plant-Derived Compounds on Amyotrophic Lateral Sclerosis. Neurotoxicity Research, 41(3), 288-309. https://doi.org/10.1007/s12640-022-00632-1
Vancouver
de Oliveira LMG, Carreira RB, de Oliveira JVR, do Nascimento RP, Dos Santos Souza C, Trias E, et al. Impact of Plant-Derived Compounds on Amyotrophic Lateral Sclerosis. Neurotoxicity Research. 2023;41(3):288-309. doi:10.1007/s12640-022-00632-1
BibTeX
@article{deOliveira2023,
author = {de Oliveira, Lucas Matheus Gonçalves and Carreira, Rodrigo Barreto and de Oliveira, Juciele Valeria Ribeiro and do Nascimento, Ravena Pereira and Dos Santos Souza, Cleide and Trias, Emiliano and da Silva, Victor Diogenes Amaral and Costa, Silvia Lima},
title = {Impact of Plant-Derived Compounds on Amyotrophic Lateral Sclerosis},
journal = {Neurotoxicity Research},
year = {2023},
volume = {41},
number = {3},
pages = {288--309},
doi = {10.1007/s12640-022-00632-1}
}
EUVIMED